Alice Valder Curran discusses how the industry continues to strategize around this complicated order.
Alice Valder Curan
Advertisement
Alice Valdur Curan is partner at Hogan Lowells.
Articles by Alice Valder Curan
Advertisement
Latest Updated Articles
The Ongoing Impact of MFN PricingMarch 5th 2026
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
3
Pharma M&A Roundup: Gilead Sciences Expands Collaboration with World Health Organization, Johnson & Johnson Enters Collaboration with Department of Health - Abu Dhabi
4
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
5